keyword
https://read.qxmd.com/read/38643073/advanced-in-immunological-monitoring-of-hiv-infection-profile-of-immune-cells-and-cytokines-in-people-living-with-hiv-1-in-benin
#1
JOURNAL ARTICLE
Yaou Pierrot Assogba, Adefounke Prudencia Adechina, Edmond Tchiakpe, Odilon Paterne Nouatin, René K Kèkè, Moussa Bachabi, Honoré Sourou Bankole, Akadiri Yessoufou
BACKGROUND: Immune cells and cytokines have been linked to viremia dynamic and immune status during HIV infection. They may serve as useful biomarkers in the monitoring of people living with HIV-1 (PLHIV-1). The present work was aimed to assess whether cytokines and immune cell profiles may help in the therapeutic follow-up of PLHIV-1. METHODS: Forty PLHIV-1 in treatment success (PLHIV-1s) and fifty PLHIV-1 in treatment failure (PLHIV-1f) followed at the University Hospital of Abomey-Calavi/Sô-Ava in Benin were enrolled...
April 20, 2024: BMC Immunology
https://read.qxmd.com/read/38631429/the-association-of-infant-urinary-adrenal-steroids-with-the-risk-of-childhood-asthma-development
#2
JOURNAL ARTICLE
Kedir N Turi, Yajing Li, Yaomin Xu, Tebeb Gebretsadik, Christian Rosas-Salazar, Derek A Wiggins, Chris McKennan, Dawn Newcomb, James E Gern, Tina V Hartert
BACKGROUND: Adrenal steroids play important roles in early life development. However, our understanding of the effects of perinatal adrenal steroids on the development of childhood asthma is incomplete. OBJECTIVE: This study aimed to evaluate the associations between early life adrenal steroid levels and childhood asthma. METHODS: Participants included INSPIRE birth cohort children with untargeted urinary metabolomics data measured during early infancy (n=264) and nasal immune mediator data measured concurrently at age 2-6 months (n=76)...
April 15, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38631146/hydrangea-serrata-extract-attenuates-pm-exacerbated-airway-inflammation-in-the-caras-model-by-modulating-the-il-33-st2-nf-%C3%AE%C2%BAb-signaling-pathway
#3
JOURNAL ARTICLE
Juan Jin, Thi Van Nguyen, Yuna Jiang, Zhen Nan Yu, Chang Ho Song, So-Young Lee, Hee Soon Shin, Ok Hee Chai
Particulate matter (PM) significantly contributes to the global health crisis of respiratory diseases. It is known to induce and exacerbate conditions such as asthma and respiratory infections. Long exposure to PM can increase the risk of combined allergic rhinitis and asthma syndrome (CARAS). Although therapeutic drugs can be used to improve symptoms of respiratory diseases caused by PM, their usage is often accompanied by side effects. Therefore, many studies are being conducted to discover functional food materials that can more effectively treat respiratory diseases while minimizing the side effects of these therapeutic drugs...
April 16, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38626359/trajectories-of-inflammatory-markers-and-post-covid-19-cognitive-symptoms-a-secondary-analysis-of-the-contain-covid-19-randomized-trial
#4
JOURNAL ARTICLE
Jennifer A Frontera, Rebecca A Betensky, Liise-Anne Pirofski, Thomas Wisniewski, Hyunah Yoon, Mila B Ortigoza
BACKGROUND AND OBJECTIVES: Chronic systemic inflammation has been hypothesized to be a mechanistic factor leading to post-acute cognitive dysfunction after COVID-19. However, little data exist evaluating longitudinal inflammatory markers. METHODS: We conducted a secondary analysis of data collected from the CONTAIN randomized trial of convalescent plasma in patients hospitalized for COVID-19, including patients who completed an 18-month assessment of cognitive symptoms and PROMIS Global Health questionnaires...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38623926/exploring-novel-perspectives-on-eosinophilic-inflammation-in-severe-asthma
#5
JOURNAL ARTICLE
Claudio Candia, Pasquale Ambrosino, Silvestro E D'Anna, Andrea Motta, Mauro Maniscalco
Two recent articles by the same research group documented that patients with severe eosinophilic asthma exhibit an increased proportion of a subtype of eosinophils, namely CD62Llow inflammatory eosinophils (iEos) and identified an intriguing correlation between such iEos and asthma control scores. Moreover, CD62Llow iEos were reduced after treatment with the anti-IL-5 monoclonal antibody mepolizumab. In the future, we believe that eosinophil subtypes could represent a useful biomarker in severe eosinophilic asthma, helping clinicians characterize patient endotypes and monitoring the response to biological drugs...
April 16, 2024: Biomarkers in Medicine
https://read.qxmd.com/read/38619468/advancements-in-biologic-therapy-in-eosinophilic-asthma
#6
REVIEW
Rini Patadia, Thomas B Casale, John Fowler, Shiven Patel, Juan Carlos Cardet
INTRODUCTION: Asthma encompasses a spectrum of phenotypes often categorized into two groups- type 2 high (T2 high) and type 2 low (T2 low). T2 high includes atopic and eosinophilic presentations whereas T2 low is non-atopic, non-eosinophilic, and oft associated with neutrophilic inflammation. Eosinophilic asthma is often driven by IgE, IL-4, IL-5, and IL-13 and TSLP. This can lead to eosinophilic inflammatory response in the airways which in turn can be used as target for treatment. AREAS COVERED: The article will focus on biologic therapy that is currently being used in eosinophilic asthma management in mainly the adult population including clinical trials and co-morbidities that can be treated using the same biologics...
April 15, 2024: Expert Opinion on Biological Therapy
https://read.qxmd.com/read/38616237/sub-acute-oral-exposure-to-lowest-observed-adverse-effect-level-of-nivalenol-exacerbates-atopic-dermatitis-in-mice-via-direct-activation-of-mitogen-activated-protein-kinase-signal-in-antigen-presenting-cells
#7
JOURNAL ARTICLE
Reo Matsuzaka, Hiroki Yamaguchi, Chiharu Ohira, Tomoe Kurita, Naoki Iwashita, Yoshiichi Takagi, Tomomi Nishino, Kyoko Noda, Kazutoshi Sugita, Masayo Kushiro, Shiro Miyake, Tomoki Fukuyama
This study investigated the immunotoxic effects of the mycotoxin nivalenol (NIV) using antigen-presenting cells and a mouse model of atopic dermatitis (AD). In vitro experiments were conducted using a mouse macrophage cell line (RAW 264.7) and mouse dendritic cell line (DC 2.4). After cells were exposed to NIV (0.19-5 µmol) for 24 h, the production of pro-inflammatory cytokines (IL-1β, IL-6, and TNFα) was quantified. To further investigate the inflammatory cytokine production pathway, the possible involvement of mitogen-activated protein kinase (MAPK) pathways, such as ERK1/2, p-38, and JNK, in NIV exposure was analyzed using MAPK inhibitors and phosphorylation analyses...
April 14, 2024: Archives of Toxicology
https://read.qxmd.com/read/38614096/structure-of-the-interleukin-5-receptor-complex-exemplifies-the-organizing-principle-of-common-beta-cytokine-signaling
#8
JOURNAL ARTICLE
Nathanael A Caveney, Grayson E Rodriguez, Christoph Pollmann, Thomas Meyer, Marta T Borowska, Steven C Wilson, Nan Wang, Xinyu Xiang, Karsten D Householder, Pingdong Tao, Leon L Su, Robert A Saxton, Jacob Piehler, K Christopher Garcia
Cytokines regulate immune responses by binding to cell surface receptors, including the common subunit beta (βc), which mediates signaling for GM-CSF, IL-3, and IL-5. Despite known roles in inflammation, the structural basis of IL-5 receptor activation remains unclear. We present the cryo-EM structure of the human IL-5 ternary receptor complex, revealing architectural principles for IL-5, GM-CSF, and IL-3. In mammalian cell culture, single-molecule imaging confirms hexameric IL-5 complex formation on cell surfaces...
April 5, 2024: Molecular Cell
https://read.qxmd.com/read/38612591/a-potential-role-of-interleukin-5-in-the-pathogenesis-and-progression-of-amyotrophic-lateral-sclerosis-a-new-molecular-perspective
#9
JOURNAL ARTICLE
Anca Moțățăianu, Sebastian Andone, Adina Stoian, Rodica Bălașa, Adina Huțanu, Emanuela Sărmășan
Cumulative data suggest that neuroinflammation plays a prominent role in amyotrophic lateral sclerosis (ALS) pathogenesis. The purpose of this work was to assess if patients with ALS present a specific peripheral cytokine profile and if it correlates with neurological disability assessed by ALSFRS-R, the rate of disease progression, and the pattern of disease progression (horizontal spreading [HSP] versus vertical spreading [VSP]). We determined the levels of 15 cytokines in the blood of 59 patients with ALS and 40 controls...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38607026/an-ox-tra-ordinary-tale-the-role-of-ox40-and-ox40l-in-atopic-dermatitis
#10
REVIEW
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, Audrey Hao, Rebecca K Yamamoto, Hannah C Tolson, Sara N Bilimoria, Danielle K Yee, April W Armstrong
The transmembrane glycoprotein OX40 receptor (OX40) and its ligand, OX40L, are instrumental modulators of the adaptive immune response in humans. OX40 functions as a costimulatory molecule that promotes T cell activation, differentiation, and survival through ligation with OX40L. T cells play an integral role in the pathogenesis of several inflammatory skin conditions, including atopic dermatitis (AD). In particular, T helper 2 (TH 2) cells strongly contribute to AD pathogenesis via the production of cytokines associated with type 2 inflammation (e...
March 28, 2024: Cells
https://read.qxmd.com/read/38603858/cyp2e1-protects-against-ova-induced-allergic-rhinitis-through-the-inhibition-of-th2-cell-activation-and-differentiation-mediated-by-mafb
#11
JOURNAL ARTICLE
Weiliang Bai, Hui Su, Shengqun Xu, Zhao Gao, Ziwen Chang, Xun Sun, Tiancong Liu
Allergic rhinitis (AR) is a common allergic disease. Cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1) is a member of the cytochrome P450 family of enzymes, while its role in AR is still unveiled. In AR mice, T cell-specific overexpression of Cyp2e1 relieved the AR symptoms. Overexpressed-Cyp2e1 restrained the infiltration of eosinophils and mast cells in the nasal mucosa of mice, and the inflammatory cells in nasal lavage fluid (NALF). Cyp2e1 overexpressed mice exhibited decreased goblet cell hyperplasia and mucus secretion as well as decreased MUC5AC expression in nasal mucosa...
April 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38602307/the-level-of-cytokines-in-tears-as-a-novel-indicator-of-demyelinating-diseases
#12
JOURNAL ARTICLE
Jowita Adamczyk-Zostawa, Adam Wylęgała, Martyna Lis, Jacek Zostawa, Rafał Fiolka, Edward Wylęgała, Monika Adamczyk-Sowa, Zenon Czuba
INTRODUCTION: A novel research objective is to identify new molecules in more readily accessible biological fluids that could be used in the diagnosis of multiple sclerosis (MS) and other demyelinating disorders. AIM: To compare the level of selected cytokines in tears between patients with MS or other demyelinating disorder and healthy controls. MATERIAL AND METHODS: 84 patients with diagnosed MS during remission or with other demyelinating disease of the CNS and 70 healthy controls were enrolled in the study...
April 11, 2024: Neurological Research
https://read.qxmd.com/read/38602214/-dupilumab-a-new-treatment-for-severe-t2-high-asthma
#13
JOURNAL ARTICLE
Renaud Louis, Mare Sabbe, Nicolas Bougard, Anne-Noëlle Frix, Florence Schleich
Severe asthma often features a T2 high profile regulated by cytokines such as interleukins IL-4, IL-5 and IL-13. Dupilumab (Dupixent®) is humanized monoclonal antibody directed against the α subunit of the receptor for IL-4 and IL-13. Here we summarise the immunogical background of severe asthma which supports the use of dupilumab and the pivotal randomised controlled trials which have established the efficacy of dupilumab in treating people with severe asthma. Dupilumab reduces the exacerbation rate, has corticosteroids sparing effect, provides sustained improvement in expiratory flow rates and improved asthma control and quality of life with a reassuring safety profile...
April 2024: Revue Médicale de Liège
https://read.qxmd.com/read/38602180/electroacupuncture-reduced-airway-inflammation-by-activating-somatosensory-sympathetic-pathways-in-allergic-asthmatic-rats
#14
JOURNAL ARTICLE
Hongli Ma, Xiaowen Liu, Huamei Cai, Yun Yan, Weixia Li, Jing Zhao
BACKGROUND: Electroacupuncture (EA) treatment is efficacious in patients with respiratory disorders, although the mechanisms of its action in lung-function protection are poorly understood. This study aimed to explore the neuroanatomical mechanisms of EA stimulation at the BL13 acupoint (Feishu, EA-BL13) improvement in asthma. METHODS: Allergic asthma was induced by intranasal 2.0% ovalbumin (OVA) instillation combined with intraperitoneal injection of the 10.0% OVA...
April 10, 2024: Chinese Medical Journal
https://read.qxmd.com/read/38601813/coexistence-of-eosinophilic-granulomatosis-with-polyangiitis-and-allergic-bronchopulmonary-aspergillosis-a-fascinating-relationship
#15
Alessandro Maria Marra, Pietro Curci, Giovanni Franco, Giulia Pittalis, Erica Tugnoli, Davide Cavasin, Andrea Cristiano, Francesco Bini
Elevated eosinophil counts are associated with various diseases, including eosinophilic granulomatosis with polyangiitis (EGPA) and allergic bronchopulmonary aspergillosis (ABPA). EGPA is a rare small-vessel vasculitis characterized by asthma, eosinophilia, fleeting pulmonary infiltrates, and systemic manifestations. ABPA, initiated by immune reactions against Aspergillus fumigatus in the airways, presents with poorly controlled asthma, wheezing, hemoptysis, productive cough, and systemic symptoms, which result in characteristic central bronchiectasis...
April 2024: Curēus
https://read.qxmd.com/read/38601166/construction-by-artificial-intelligence-and-immunovalidation-of-hypoallergenic-mite-allergen-der-f-36-vaccine
#16
JOURNAL ARTICLE
Qiao-Zhi Qin, Jian Tang, Cai-Yun Wang, Zhi-Qiang Xu, Man Tian
BACKGROUND: The house dust mite (HDM) is widely recognized as the most prevalent allergen in allergic diseases. Allergen-specific immunotherapy (AIT) has been successfully implemented in clinical treatment for HDM. Hypoallergenic B-cell epitope-based vaccine designed by artificial intelligence (AI) represents a significant progression of recombinant hypoallergenic allergen derivatives. METHOD: The three-dimensional protein structure of Der f 36 was constructed using Alphafold2...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38599205/the-prostaglandin-d2-receptor-crth2-contributes-to-airway-hyperresponsiveness-during-airway-inflammation-induced-by-sensitization-without-an-adjuvant-in-mice
#17
JOURNAL ARTICLE
Satoshi Hanzawa, Makiko Sugiura, Susumu Nakae, Masahiro Masuo, Hideaki Morita, Kenji Matsumoto, Kazuyoshi Takeda, Ko Okumura, Masataka Nakamura, Tatsukuni Ohno, Yasunari Miyazaki
INTRODUCTION: Prostaglandin D2 (PGD2), which is produced mainly by Th2 cells and mast cells, promotes a type-2 immune response by activating Th2 cells, mast cells, eosinophils, and group 2 innate lymphoid cells (ILC2s) via its receptor, chemoattractant receptor-homologous molecules on Th2 cells (CRTH2). However, the role of CRTH2 in models of airway inflammation induced by sensitization without adjuvants, in which both IgE and mast cells may play major roles, remain unclear. METHODS: Wild-type (WT) and CRTH2-knockout (KO) mice were sensitized with ovalbumin (OVA) without an adjuvant and then challenged intranasally with OVA...
April 10, 2024: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38598774/neuromedin-u-mediates-rapid-activation-of-airway-group-2-innate-lymphoid-cells-in-mild-asthma
#18
JOURNAL ARTICLE
Xiaotian Ju, Akimichi Nagashima, Anna Dvorkin-Gheva, Jennifer Wattie, Karen Howie, Christiane Whetstone, Maral Ranjbar, Ruth Cusack, Reina Ditta, Guillaume Paré, Imran Satia, Paul M O'Byrne, Gail M Gauvreau, Roma Sehmi
RATIONALE: In asthma, sputum group 2 innate lymphoid cells (ILC2) are activated within 7h after allergen challenge. Neuroimmune interactions mediate rapid host responses at mucosal interfaces. In murine models of asthma, lung ILC2 co-localize to sensory neuronal termini expressing the neuropeptide, neuromedin U (NMU) and NMU stimulates type 2 cytokines secretion by ILC2 with additive effects to alarmins, in vitro . OBJECTIVES: Investigate effect of NMU/NMUR1 axis on early activation of ILC2 in asthma...
April 10, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38598121/aerobic-physical-training-reduces-severe-asthma-phenotype-involving-kinins-pathway
#19
JOURNAL ARTICLE
Maysa Alves Rodrigues Brandao-Rangel, Renilson Moraes-Ferreira, Anamei Silva-Reis, Victor Hugo Souza-Palmeira, Francine Maria Almeida, Fabiana Regina da Silva Olimpio, Carlos Rocha Oliveira, Nilsa Regina Damaceno-Rodrigues, João Bosco Pesquero, Leonardo Martin, Flavio Aimbire, Regiane Albertini, Sara Socorro Faria, Rodolfo P Vieira
INTRODUCTION: Aerobic physical training (APT) reduces eosinophilic airway inflammation, but its effects and mechanisms in severe asthma remain unknown. METHODS: An in vitro study employing key cells involved in the pathogenesis of severe asthma, such as freshly isolated human eosinophils, neutrophils, and bronchial epithelial cell lineage (BEAS-2B) and lung fibroblasts (MRC-5 cells), was conducted. Additionally, an in vivo study using male C57Bl/6 mice, including Control (Co; n = 10), Trained (Exe; n = 10), house dust mite (HDM; n = 10), and HDM + Trained (HDM + Exe; n = 10) groups, was carried out, with APT performed at moderate intensity, 5x/week, for 4 weeks...
April 10, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38597952/tl1a-is-an-epithelial-alarmin-that-cooperates-with-il-33-for-initiation-of-allergic-airway-inflammation
#20
JOURNAL ARTICLE
Pauline Schmitt, Anais Duval, Mylène Camus, Emma Lefrançais, Stéphane Roga, Cécile Dedieu, Nathalie Ortega, Elisabeth Bellard, Emilie Mirey, Emmanuelle Mouton-Barbosa, Odile Burlet-Schiltz, Anne Gonzalez-de-Peredo, Corinne Cayrol, Jean-Philippe Girard
Epithelium-derived cytokines or alarmins, such as interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP), are major players in type 2 immunity and asthma. Here, we demonstrate that TNF-like ligand 1A (TL1A) is an epithelial alarmin, constitutively expressed in alveolar epithelium at steady state in both mice and humans, which cooperates with IL-33 for early induction of IL-9high ILC2s during the initiation of allergic airway inflammation. Upon synergistic activation by IL-33 and TL1A, lung ILC2s acquire a transient IL-9highGATA3low "ILC9" phenotype and produce prodigious amounts of IL-9...
June 3, 2024: Journal of Experimental Medicine
keyword
keyword
25753
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.